With mounting evidence documenting COVID-19’s significant impact on the cardiovascular system, now is the time to get serious about Cardiac PET.
Deemed the safest stress test option during COVID-19 by ASNC and SNMMI1 for the evaluation of coronary artery disease (CAD), rapid pharmacologic Cardiac PET is a must-have for your practice.
In addition to reducing exposure-risk for patients and providers, Cardiac PET also allows for timely results.
